Stephen Connelly - Oct 6, 2021 Form 4 Insider Report for Equillium, Inc. (EQ)

Role: Chief Scientific Officer, Director
Signature: Jason A. Keyes, Attorney -in-Fact for Stephen Connelly
Stock symbol: EQ
Transactions as of: Oct 6, 2021
Transactions value $: -$23,080
Form type: 4
Date filed: 10/7/2021, 09:02 PM
Previous filing: Jun 9, 2021
Next filing: Feb 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EQ	Common Stock	Options Exercise	$26.7K	+5.63K	+0.57%	$4.75^*	999K	Oct 6, 2021	Direct
transaction	EQ	Common Stock	Sale	-$39.4K	-5.63K	-0.56%	$7.01^*	993K	Oct 6, 2021	Direct	F1, F2
transaction	EQ	Common Stock	Options Exercise	$6.91K	+2.47K	+0.25%	$2.80	995K	Oct 6, 2021	Direct
transaction	EQ	Common Stock	Sale	-$17.3K	-2.47K	-0.25%	$7.01^*	993K	Oct 6, 2021	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EQ	Employee Stock Option (right to buy)	Options Exercise	$0	-5.63K	-100%	$0.00^*	0	Oct 6, 2021	Common Stock	5.63K	$4.75	Direct	F4
transaction	EQ	Employee Stock Option (right to buy)	Options Exercise	$0	-2.47K	-100%	$0.00^*	0	Oct 6, 2021	Common Stock	2.47K	$2.80	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
F4	This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter.
F5	This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter.